Insmed Incorporated

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. 

CEO
William H. Lewis
CEOWilliam H. Lewis
Employees
912
Employees912
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
1988
Founded1988
Employees
912
Employees912

INSM Key Statistics

Market cap
3.80B
Market cap3.80B
Price-Earnings ratio
-4.78
Price-Earnings ratio-4.78
Dividend yield
—
Dividend yield—
Average volume
2.32M
Average volume2.32M
High today
$26.46
High today$26.46
Low today
$25.07
Low today$25.07
Open price
$25.07
Open price$25.07
Volume
1.61M
Volume1.61M
52 Week high
$32.00
52 Week high$32.00
52 Week low
$18.09
52 Week low$18.09

INSM News

Yahoo Finance 7d
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 - Yahoo Finance

BRIDGEWATER, N.J., April 25, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of p...

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 - Yahoo Finance

Analyst ratings

100%

of 17 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.